0001493152-24-005370.txt : 20240208
0001493152-24-005370.hdr.sgml : 20240208
20240208073009
ACCESSION NUMBER: 0001493152-24-005370
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240207
FILED AS OF DATE: 20240208
DATE AS OF CHANGE: 20240208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOLL ANDREW R.
CENTRAL INDEX KEY: 0001542150
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 24606862
MAIL ADDRESS:
STREET 1: 437 S HWY 101
STREET 2: STE 209
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER NAME:
FORMER CONFORMED NAME: Boll Andrew
DATE OF NAME CHANGE: 20120210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARROW, INC.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
BUSINESS PHONE: 615.733.4731
MAIL ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
FORMER COMPANY:
FORMER CONFORMED NAME: HARROW HEALTH, INC.
DATE OF NAME CHANGE: 20181228
FORMER COMPANY:
FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20120301
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
4
1
ownership.xml
X0508
4
2024-02-07
0
0001360214
HARROW, INC.
HROW
0001542150
BOLL ANDREW R.
C/O HARROW, INC.
102 WOODMONT BLVD, SUITE 610
NASHVILLE
TN
37205
0
1
0
0
CHIEF FINANCIAL OFFICER
0
Common stock
2024-02-07
4
M
0
7400
7.71
A
541569
D
Stock Option (Right to Buy)
7.71
2024-02-07
4
M
0
7400
0
D
2024-02-10
Common Stock
7400
0
D
Represents stock options granted to Mr. Boll on February 10, 2014 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock option vested quarterly over a three-year period following the grant date. The total exercise price for the options ($57,054) was paid in cash to the Issuer by Mr. Boll.
/s/ Andrew R. Boll
2024-02-08